Prenetics is first Hong Kong firm to take genetic test kit for cancer risk direct to consumers

• The kit will assess the user’s risk of developing eight hereditary cancers within his or her lifetime
• The nascent consumer genetic-testing market is projected to grow at 15 per cent annually to reach US$928 million by 2023